Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes Chief Scientific Officer gave up 459 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Scientific Officer gave up 698 shares (to pay taxes)
  7. 4 Shares withheld for taxes Chief Scientific Officer gave up 3,035 shares (to pay taxes)
  8. 4/A Open-market buy Director bought 41,200 shares at $0.85 ($35,020)
  9. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,731 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 41,200 shares at $0.85 ($35,020)
  12. 4/A Open-market buy Director bought 10,000 shares at $0.80 ($8,000)
  13. 4/A Open-market buy Director bought 10,000 shares at $0.80 ($8,000)
  14. 4 Open-market buy Director bought 10,000 shares at $0.80 ($8,000)
  15. 4 Open-market buy Director bought 10,000 shares at $0.80 ($8,000)
  16. 4 Shares withheld for taxes Chief Scientific Officer gave up 42,930 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 62,010 shares (to pay taxes)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 8 of 15 · 300 filings